Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Adoption, Sustainability, and Dissemination of Chronic Disease Prevention Policies in Community-Based Organizations.

Leser KA, Liu ST, Smathers CA, Graffagnino CL, Pirie PL.

Health Promot Pract. 2019 Jun 3:1524839919850757. doi: 10.1177/1524839919850757. [Epub ahead of print]

PMID:
31155948
2.

A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).

Savitz SI, Yavagal D, Rappard G, Likosky W, Rutledge N, Graffagnino C, Alderazi Y, Elder JA, Chen PR, Budzik RF Jr, Tarrel R, Huang DY, Hinson JM Jr.

Circulation. 2019 Jan 8;139(2):192-205. doi: 10.1161/CIRCULATIONAHA.117.030659.

PMID:
30586746
3.

Assessment of healthcare personnel knowledge of stroke care at a large referral hospital in sub-Saharan Africa - A survey based approach.

Lin C, Vakani R, Kussin P, Guhwe M, Farjat AE, Choudhury K, Renner D, Oduor C, Graffagnino C; Neuroscience Knowledge Base Investigator Group.

J Clin Neurosci. 2017 Aug;42:71-74. doi: 10.1016/j.jocn.2017.04.013. Epub 2017 Apr 28.

PMID:
28457860
4.

Symbiotic relationship of IV-tPA and mechanical thrombectomy in a case of acute tandem ICA-MCA occlusion.

Cobb MI, Bruce DJ, Graffagnino C, Hauck EF.

J Clin Neurosci. 2017 Apr;38:68-71. doi: 10.1016/j.jocn.2016.12.025. Epub 2017 Jan 16.

PMID:
28110931
5.

Toward Solving the Sedation-Assessment Conundrum: Neurofunction Monitoring.

Olson DM, Phillips K, Graffagnino C.

Crit Care Nurs Clin North Am. 2016 Jun;28(2):205-16. doi: 10.1016/j.cnc.2016.02.007. Epub 2016 Mar 3. Review.

PMID:
27215358
6.

Current advances in the use of therapeutic hypothermia.

Graffagnino C, Erlinge D, Keeble T, Nichol G.

Ther Hypothermia Temp Manag. 2015 Mar;5(1):9-12. doi: 10.1089/ther.2015.1502. No abstract available.

PMID:
25692221
7.

The disappearing thrombus: An uncommon cause of ischemic stroke.

Lerner DP, Graffagnino C.

Neurol Clin Pract. 2014 Dec;4(6):534-535. doi: 10.1212/CPJ.0000000000000039. No abstract available.

8.

Therapeutic hypothermia in post-cardiac arrest.

Polderman K, Nielsen N, Graffagnino C, Wayne M.

Ther Hypothermia Temp Manag. 2014 Dec;4(4):154-8. doi: 10.1089/ther.2014.1515. No abstract available.

PMID:
25402717
9.

Neurological complications of cardiac surgery.

McDonagh DL, Berger M, Mathew JP, Graffagnino C, Milano CA, Newman MF.

Lancet Neurol. 2014 May;13(5):490-502. doi: 10.1016/S1474-4422(14)70004-3. Epub 2014 Apr 2. Review.

10.

Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.

Graffagnino C, Bergese S, Love J, Schneider D, Lazaridis C, LaPointe M, Lee K, Lynch G, Hu MY, Williams GC.

Cerebrovasc Dis. 2013;36(3):173-80. doi: 10.1159/000351149. Epub 2013 Oct 12.

PMID:
24135526
11.

Exploring the impact of augmenting sedation assessment with physiologic monitors.

Olson DM, Zomorodi MG, James ML, Cox CE, Moretti EW, Riemen KE, Graffagnino C.

Aust Crit Care. 2014 Aug;27(3):145-50. doi: 10.1016/j.aucc.2013.09.001. Epub 2013 Oct 5.

PMID:
24103486
12.

Continuous cerebral spinal fluid drainage associated with complications in patients admitted with subarachnoid hemorrhage.

Olson DM, Zomorodi M, Britz GW, Zomorodi AR, Amato A, Graffagnino C.

J Neurosurg. 2013 Oct;119(4):974-80. doi: 10.3171/2013.6.JNS122403. Epub 2013 Aug 20.

PMID:
23957382
13.

Hyperdense posterior cerebral artery sign in a setting of spontaneous vertebral artery dissection: a blessing in disguise?

Gokhale S, Graffagnino C.

Med Princ Pract. 2014;23(1):86-8. doi: 10.1159/000351694. Epub 2013 Jul 26.

14.
15.

Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention.

Olson DM, Bettger JP, Alexander KP, Kendrick AS, Irvine JR, Wing L, Coeytaux RR, Dolor RJ, Duncan PW, Graffagnino C.

Evid Rep Technol Assess (Full Rep). 2011 Oct;(202):1-197. Review.

16.

Transitional care after hospitalization for acute stroke or myocardial infarction: a systematic review.

Prvu Bettger J, Alexander KP, Dolor RJ, Olson DM, Kendrick AS, Wing L, Coeytaux RR, Graffagnino C, Duncan PW.

Ann Intern Med. 2012 Sep 18;157(6):407-16. doi: 10.7326/0003-4819-157-6-201209180-00004. Review.

PMID:
22986378
17.

Therapeutic hypothermia in post-cardiac arrest.

Ornato JP, Graffagnino C, Friberg H, Mooney MR, Herzog E.

Ther Hypothermia Temp Manag. 2012 Sep;2(3):109-11. doi: 10.1089/ther.2012.1513. No abstract available.

PMID:
24716448
18.

An observational pilot study of CSF diversion in subarachnoid haemorrhage.

Amato A, Britz GW, James ML, Graffagnino C, Zomorodi AR, Zomorodi ME, Olson DM.

Nurs Crit Care. 2011 Sep-Oct;16(5):252-60. doi: 10.1111/j.1478-5153.2010.00444.x. Erratum in: Nurs Crit Care. 2012 Jan-Feb;17(1):56.

PMID:
21824230
19.

Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.

Graffagnino C, Gurram AR, Kolls B, Olson DM.

Neurocrit Care. 2010 Dec;13(3):307-12. doi: 10.1007/s12028-010-9469-4.

PMID:
21086066
20.

Continuous and intermittent CSF diversion after subarachnoid hemorrhage: a pilot study.

Kim GS, Amato A, James ML, Britz GW, Zomorodi A, Graffagnino C, Zomorodi M, Olson DM.

Neurocrit Care. 2011 Feb;14(1):68-72. doi: 10.1007/s12028-010-9401-y.

PMID:
20596794
21.

Timing of symptomatic vasospasm in aneurysmal subarachnoid hemorrhage: the effect of treatment modality and clinical implications.

Ionita CC, Baker J, Graffagnino C, Alexander MJ, Friedman AH, Zaidat OO.

J Stroke Cerebrovasc Dis. 2010 Mar;19(2):110-5. doi: 10.1016/j.jstrokecerebrovasdis.2009.11.009.

PMID:
20189086
22.

Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program.

Snow R, Ruane J, LaLonde M, Shaffer L, Kim B, Graffagnino C, Falko J, Spencer K, Caulin-Glaser T.

J Cardiopulm Rehabil Prev. 2010 May-Jun;30(3):173-80. doi: 10.1097/HCR.0b013e3181c565c8.

PMID:
20040884
23.

Effect of mechanical chest percussion on intracranial pressure: a pilot study.

Olson DM, Thoyre SM, Bennett SN, Stoner JB, Graffagnino C.

Am J Crit Care. 2009 Jul;18(4):330-5. doi: 10.4037/ajcc2009523. Epub 2009 Mar 19.

24.

A randomized evaluation of bispectral index-augmented sedation assessment in neurological patients.

Olson DM, Thoyre SM, Peterson ED, Graffagnino C.

Neurocrit Care. 2009;11(1):20-7. doi: 10.1007/s12028-008-9184-6. Epub 2009 Jan 29.

25.

Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).

Aronow HD, Califf RM, Harrington RA, Vallee M, Graffagnino C, Shuaib A, Fitzgerald DJ, Easton JD, Van de Werf F, Diener HC, Ferguson J, Koudstaal PJ, Amarenco P, Theroux P, Davis S, Topol EJ.

Am J Cardiol. 2008 Nov 15;102(10):1285-90. doi: 10.1016/j.amjcard.2008.07.019. Epub 2008 Sep 15.

PMID:
18993142
26.

Impact of ruptured cerebral aneurysm coiling and clipping on the incidence of cerebral vasospasm and clinical outcome.

Zaidat OO, Ionita CC, Hussain SI, Alexander MJ, Friedman AH, Graffagnino C.

J Neuroimaging. 2009 Apr;19(2):144-9. doi: 10.1111/j.1552-6569.2008.00285.x. Epub 2008 Aug 4.

PMID:
18681928
27.

Effect of a weight management program on the determinants and prevalence of metabolic syndrome.

La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T.

Obesity (Silver Spring). 2008 Mar;16(3):637-42. doi: 10.1038/oby.2007.86. Epub 2008 Jan 17.

28.
29.

The limited reliability of the Ramsay scale.

Olson D, Lynn M, Thoyre SM, Graffagnino C.

Neurocrit Care. 2007;7(3):227-31.

PMID:
17896083
30.

Use of high frequency oscillatory ventilation (HFOV) in neurocritical care patients.

Bennett SS, Graffagnino C, Borel CO, James ML.

Neurocrit Care. 2007;7(3):221-6.

31.

Changes in intracranial pressure associated with chest physiotherapy.

Olson DM, Thoyre SM, Turner DA, Bennett S, Graffagnino C.

Neurocrit Care. 2007;6(2):100-3.

PMID:
17522792
32.

Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience.

McGirt MJ, Blessing R, Alexander MJ, Nimjee SM, Woodworth GF, Friedman AH, Graffagnino C, Laskowitz DT, Lynch JR.

J Neurosurg. 2006 Nov;105(5):671-4.

PMID:
17121126
33.

Statin use and sex-specific stroke outcomes in patients with vascular disease.

Bushnell CD, Griffin J, Newby LK, Goldstein LB, Mahaffey KW, Graffagnino CA, Harrington RA, White HD, Simes RJ, Califf RM, Topol EJ, Easton JD.

Stroke. 2006 Jun;37(6):1427-31. Epub 2006 Apr 27.

PMID:
16645137
34.

Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors.

Graffagnino CL, Falko JM, La Londe M, Schaumburg J, Hyek MF, Shaffer LE, Snow R, Caulin-Glaser T.

Obesity (Silver Spring). 2006 Feb;14(2):280-8.

35.
36.

Consciousness, coma, and caring for the brain-injured patient.

Olson DM, Graffagnino C.

AACN Clin Issues. 2005 Oct-Dec;16(4):441-55. Review.

PMID:
16269891
37.

Toward solving the sedation-assessment conundrum: bi-spectral index monitoring and sedation interruption.

Olson DM, Graffagnino C, King K, Lynch JR.

Crit Care Nurs Clin North Am. 2005 Sep;17(3):257-67. Review.

PMID:
16115534
38.

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.

Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT.

Stroke. 2005 Sep;36(9):2024-6. Epub 2005 Jul 28.

PMID:
16051891
39.

Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke.

Zaidat OO, Slivka AP, Mohammad Y, Graffagnino C, Smith TP, Enterline DS, Christoforidis GA, Alexander MJ, Landis DM, Suarez JI.

Stroke. 2005 May;36(5):1089-90. Epub 2005 Mar 31.

PMID:
15802636
40.

Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.

Kassem-Moussa H, Mahaffey KW, Graffagnino C, Tasissa G, Sila CA, Simes RJ, White HD, Califf RM, Bhapkar MV, Newby LK; SYMPHONY and 2nd SYMPHONY Investigators.

Am Heart J. 2004 Sep;148(3):439-46.

PMID:
15389230
41.

A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest.

Al-Senani FM, Graffagnino C, Grotta JC, Saiki R, Wood D, Chung W, Palmer G, Collins KA.

Resuscitation. 2004 Aug;62(2):143-50.

PMID:
15294399
42.

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.

Topol EJ, Easton D, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT; Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators.

Circulation. 2003 Jul 29;108(4):399-406. Epub 2003 Jul 21.

PMID:
12874182
43.

Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage.

McCarron MO, Weir CJ, Muir KW, Hoffmann KL, Graffagnino C, Nicoll JA, Lees KR, Alberts MJ.

Acta Neurol Scand. 2003 Feb;107(2):106-9.

PMID:
12580859
44.

Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies.

Kassem-Moussa H, Graffagnino C.

Arch Neurol. 2002 Dec;59(12):1870-3. Review.

PMID:
12470173
45.

De novo cerebral arteriovenous malformation: case report.

Bulsara KR, Alexander MJ, Villavicencio AT, Graffagnino C.

Neurosurgery. 2002 May;50(5):1137-40; discussion 1140-1.

PMID:
11950419
46.

Familial clustering of intracerebral hemorrhage: a prospective study in North Carolina.

Alberts MJ, McCarron MO, Hoffmann KL, Graffagnino C.

Neuroepidemiology. 2002 Jan-Feb;21(1):18-21.

PMID:
11744821
47.

Feasibility and safety of moderate hypothermia after massive hemispheric infarction.

Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, Mayer SA.

Stroke. 2001 Sep;32(9):2033-5.

PMID:
11546893
48.

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.

Harrington RA, Armstrong PW, Graffagnino C, Van De Werf F, Kereiakes DJ, Sigmon KN, Card T, Joseph DM, Samuels R, Granett J, Chan R, Califf RM, Topol EJ.

Circulation. 2000 Aug 15;102(7):728-35.

PMID:
10942739
49.

Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.

Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J.

Am Heart J. 2000 Jun;139(6):927-33.

PMID:
10827369
50.

Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.

Mahaffey KW, Harrington RA, Simoons ML, Granger CB, Graffagnino C, Alberts MJ, Laskowitz DT, Miller JM, Sloan MA, Berdan LG, MacAulay CM, Lincoff AM, Deckers J, Topol EJ, Califf RM.

Circulation. 1999 May 11;99(18):2371-7.

PMID:
10318656

Supplemental Content

Loading ...
Support Center